
Brixadi is a long-acting buprenorphine formulation for the treatment of moderate to severe opioid use disorder. This prefilled syringe delivers a 16 mg weekly subcutaneous dose in a 0.32 mL volume, providing a convenient once-weekly administration option. Each syringe is individually packaged for single use.
Sorted by lowest price · Add now, sign in at checkout


Sorted by lowest price · Add now, sign in at checkout

Brixadi is a long-acting buprenorphine formulation for the treatment of moderate to severe opioid use disorder. This prefilled syringe delivers a 16 mg weekly subcutaneous dose in a 0.32 mL volume, providing a convenient once-weekly administration option. Each syringe is individually packaged for single use.
1 vendor
Products you might be interested in